Section Editor: Kianoosh Keyhanian MD FRCPC
September 2, 2026
A cellular leiomyoma is a noncancerous (benign) tumor that develops in the muscular wall of the uterus, which is called the myometrium. Leiomyomas are made of smooth muscle cells, the same cells that make up the normal wall of the uterus. In the uterus, leiomyoma and fibroid mean the same thing, so a cellular leiomyoma is a type of fibroid.

The word “cellular” describes what the pathologist sees. In an ordinary fibroid, the muscle cells are spread apart in abundant collagen. In a cellular leiomyoma, the cells are packed more tightly together, with less collagen between them. That difference in density is the only thing separating the two diagnoses.
A cellular leiomyoma is not cancer, and it does not spread to other parts of the body. Doctors treat it like any other fibroid. This article will help you understand what this diagnosis means on your pathology report, what each term means, and why it matters for your care.
The cause of fibroids is not fully understood. Each one grows from a single smooth muscle cell that begins dividing more than it should, and its growth depends on estrogen and progesterone. That is why fibroids appear during the reproductive years and often shrink after menopause.
Several factors increase the risk of fibroids, including a family history, starting periods at an early age, and excess body weight. Fibroids are more common and tend to appear earlier in Black women than in other groups. Nothing is known to make the cellular type specifically more likely; the increased cell density is a variation in appearance rather than a different disease.
An infection does not cause fibroids, they are not contagious, and nothing you did caused this one.
A cellular leiomyoma causes the same symptoms as any other fibroid, and small ones usually cause none. Many are found by chance when the uterus is examined for another reason. Symptoms depend on the size of the tumor and where it sits in the wall of the uterus.
Fibroids are usually seen first on an ultrasound or MRI, but no imaging test can tell a cellular leiomyoma from any other fibroid. The distinction is made only under the microscope, after the tumor has been removed.
The tissue reaches the laboratory after a myomectomy, in which the fibroid is removed alone, or after a hysterectomy. In many cases, the uterus was removed for another reason, and the fibroid was an incidental finding.
A pathologist then examines the tumor, comparing its cell density with the surrounding muscle wall and assessing how the cells look. When the tumor is densely cellular, pathologists sometimes perform additional stains, as described below.
A cellular leiomyoma is a benign smooth muscle tumor of the uterus in which the cells are packed more tightly together than usual. Under the microscope, the pathologist looks for the following features.
A small number of these tumors are described as highly cellular leiomyomas. The cells are packed even more tightly, and the tumor edge may extend irregularly into the surrounding wall. This appearance can resemble another type of tumor, which is why stains are used in these cases.
Immunohistochemistry is a laboratory test that uses antibodies to detect specific proteins inside cells. Most cellular leiomyomas need no additional testing. Stains are used when the tumor is densely cellular. A densely cellular fibroid can look similar to a tumor arising from the lining tissue of the uterus rather than from muscle. Those tumors are called endometrial stromal tumors, and some of them are cancers, so the distinction matters.
No single stain settles this question, and pathologists use the three together with the appearance of the tumor. If your report lists these stains, they were performed to confirm that the tumor came from muscle.
As fibroids grow and age, parts of the tumor may begin to break down. Pathologists call this degenerative change. It is very common in cellular leiomyomas, especially in larger tumors that have been present for a long time, and it does not mean the tumor is cancerous.
Some fibroids grow so large that blood cannot reach the entire tumor. Cells that lose their blood supply die, a process called necrosis. When the pattern of cell death resembles an infarct, meaning an area of tissue killed by loss of blood supply, it is called infarct-like necrosis. This is also common after treatment with hormone medication or after uterine artery embolization, a procedure that deliberately blocks blood flow to shrink a fibroid.
The word necrosis also appears in the criteria used to diagnose cancer, so seeing it in a benign report is understandably confusing. The two are not the same. Infarct-like necrosis follows loss of blood supply and shows a zone of healing tissue between the dead and living areas. Tumor cell necrosis, the kind that counts toward a diagnosis of cancer, has an abrupt border with no healing zone. Distinguishing between them is a routine part of the pathologist’s assessment.
A uterine leiomyosarcoma is a cancer made of the same kind of smooth muscle cells. Pathologists separate it from a benign fibroid using three features together.
Cell density is not one of them. A cellular leiomyoma has more cells than usual and none of these three features, which is why it is benign. If your report says cellular leiomyoma, the pathologist assessed all three and did not find them.
Fibroids come in several forms that differ in appearance under the microscope. Your report may use any of the following terms, and the first four are all benign.
Your report will describe the tumor and the rest of the uterus. Findings commonly listed include:
A cellular leiomyoma is a benign fibroid and is managed like any other fibroid. It is not given a grade,e and it is not assigned a stage, because grading and staging describe cancers. Points your doctor may raise include:
Most people need no further treatment. Your doctor will tell you whether any follow-up is recommended in your situation.
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name